AGL 38.78 Decreased By ▼ -0.72 (-1.82%)
AIRLINK 194.29 Increased By ▲ 17.66 (10%)
BOP 10.84 Increased By ▲ 0.75 (7.43%)
CNERGY 6.87 No Change ▼ 0.00 (0%)
DCL 10.19 Increased By ▲ 0.26 (2.62%)
DFML 43.13 Increased By ▲ 0.39 (0.91%)
DGKC 96.61 Decreased By ▼ -1.56 (-1.59%)
FCCL 38.07 Decreased By ▼ -1.24 (-3.15%)
FFBL 81.43 Decreased By ▼ -0.43 (-0.53%)
FFL 14.03 Decreased By ▼ -0.36 (-2.5%)
HUBC 118.98 Decreased By ▼ -2.46 (-2.03%)
HUMNL 14.77 Decreased By ▼ -0.57 (-3.72%)
KEL 5.74 Increased By ▲ 0.08 (1.41%)
KOSM 8.49 Increased By ▲ 0.37 (4.56%)
MLCF 46.54 Decreased By ▼ -1.57 (-3.26%)
NBP 77.23 Increased By ▲ 1.41 (1.86%)
OGDC 194.78 Decreased By ▼ -2.63 (-1.33%)
PAEL 34.74 Increased By ▲ 2.36 (7.29%)
PIBTL 8.38 Increased By ▲ 0.23 (2.82%)
PPL 174.57 Decreased By ▼ -0.93 (-0.53%)
PRL 33.17 Decreased By ▼ -0.92 (-2.7%)
PTC 24.57 Increased By ▲ 2.23 (9.98%)
SEARL 110.04 Increased By ▲ 6.84 (6.63%)
TELE 8.90 Increased By ▲ 0.39 (4.58%)
TOMCL 34.83 Decreased By ▼ -0.20 (-0.57%)
TPLP 11.69 Increased By ▲ 0.43 (3.82%)
TREET 18.56 Decreased By ▼ -0.59 (-3.08%)
TRG 60.06 Increased By ▲ 1.50 (2.56%)
UNITY 36.49 Increased By ▲ 1.63 (4.68%)
WTL 1.75 Increased By ▲ 0.16 (10.06%)
BR100 11,701 Increased By 49.8 (0.43%)
BR30 35,411 Decreased By -67.2 (-0.19%)
KSE100 109,054 Increased By 815 (0.75%)
KSE30 33,849 Increased By 155.6 (0.46%)

Pfizer vaccine doses

J&J raises forecasts, estimates $2.5bn in COVID-19 vaccine sales
Business & Finance

J&J raises forecasts, estimates $2.5bn in COVID-19 vaccine sales

  • Pfizer and Moderna forecast $26 billion and $19.2 billion in annual sales of their vaccines, respectively
  • J&J raised its expectations for full-year sales to a range of $93.8 billion to $94.6 billion including contribution from the single-dose vaccine, and to $91.3 billion-$92.1 billion for the rest of the business
Published 21 Jul, 2021 05:53pm
EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents
World

EU regulator backs Pfizer-BioNTech COVID-19 vaccine for adolescents

  • The European Medicines Agency's endorsement comes weeks after it began evaluating extending use of the vaccine, developed with Germany's BioNTech, to include 12- to 15-year-olds. It is already being used in the European Union for those aged 16 and older.
  • Inoculating children and young people is considered a critical step toward reaching "herd immunity" and taming the pandemic.
Published 28 May, 2021 08:23pm
Moderna to deliver 25 million COVID-19 vaccine doses to Australia
Business & Finance

Moderna to deliver 25 million COVID-19 vaccine doses to Australia

  • It has been trying to speed up the rollout of jabs after it was stalled by supply hold-ups in Europe and concerns about blood clots tied to the AstraZeneca shot.
  • The deal also includes the supply of 15 million doses of Moderna's updated variant booster vaccine candidate to be delivered in 2022, the company said.
Published 12 May, 2021 05:16pm
Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU
Business & Finance

Pfizer, BioNTech seek to extend COVID-19 vaccine use to adolescents in EU

  • The companies filed a similar request in the United States earlier this month for the vaccine, which is already authorized for use in people from 16 years of age in both the United States and the European Union.
  • The submissions are based on positive data from a late-stage clinical trial that enrolled 2,260 participants aged 12 to 15, the companies said.
Published 30 Apr, 2021 04:51pm
South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses
Business & Finance

South Korea signs with Pfizer for additional 40mn COVID-19 vaccine doses

  • It added that it had secured a total 192 million doses of vaccines, including those from Moderna Inc, AstraZeneca PLC, Johnson & Johnson's and Novavax.
  • "The government has acquired COVID-19 vaccines large enough to vaccinate approximately 100 million people...(which) is double the entire population of South Korea," Health Minister Kwon Deok-cheol told a briefing.
Published 24 Apr, 2021 05:58pm
UK doctors call for shorter gap between Pfizer vaccine doses
World

UK doctors call for shorter gap between Pfizer vaccine doses

Britain is prioritising giving first doses of COVID-19 vaccine, allowing up to 12 weeks before a second dose, to give the maximum number of people some initial protection. * It therefore urged the CMO to "urgently review the UK's current position of second doses after 12 weeks".
Published 23 Jan, 2021 06:22pm